Medical Care
Global Pediatric Clinical Trials Market Research Report 2025
- Jul 08, 25
- ID: 347725
- Pages: 94
- Figures: 97
- Views: 1
The global market for Pediatric Clinical Trials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Pediatric Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pediatric Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pediatric Clinical Trials in Neuropsychiatric Conditions is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pediatric Clinical Trials include IQVIA Holdings, Inc., Parexel International, CenterWatch, Syneos Health, Charles River Laboratories, Covance Inc., ICON Plc., Pharmaceutical Product Development, LLC., Genentech (Roche), Pfizer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pediatric Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Clinical Trials.
The Pediatric Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IQVIA Holdings, Inc.
Parexel International
CenterWatch
Syneos Health
Charles River Laboratories
Covance Inc.
ICON Plc.
Pharmaceutical Product Development, LLC.
Genentech (Roche)
Pfizer
Bristol-Myers Squibb
GlaxoSmithKline
Sanofi S.A.
Novartis AG
Johnson & Johnson
Shire (Takeda)
Segment by Type
Pre-Clinical Phase
Phase I
Phase II
Phase III
Segment by Application
Neuropsychiatric Conditions
Infectious Diseases
Respiratory Diseases
Cardiovascular Diseases
Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Clinical Trials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Pediatric Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pediatric Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pediatric Clinical Trials in Neuropsychiatric Conditions is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pediatric Clinical Trials include IQVIA Holdings, Inc., Parexel International, CenterWatch, Syneos Health, Charles River Laboratories, Covance Inc., ICON Plc., Pharmaceutical Product Development, LLC., Genentech (Roche), Pfizer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pediatric Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Clinical Trials.
The Pediatric Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IQVIA Holdings, Inc.
Parexel International
CenterWatch
Syneos Health
Charles River Laboratories
Covance Inc.
ICON Plc.
Pharmaceutical Product Development, LLC.
Genentech (Roche)
Pfizer
Bristol-Myers Squibb
GlaxoSmithKline
Sanofi S.A.
Novartis AG
Johnson & Johnson
Shire (Takeda)
Segment by Type
Pre-Clinical Phase
Phase I
Phase II
Phase III
Segment by Application
Neuropsychiatric Conditions
Infectious Diseases
Respiratory Diseases
Cardiovascular Diseases
Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Clinical Trials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Clinical Trials Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pre-Clinical Phase
1.2.3 Phase I
1.2.4 Phase II
1.2.5 Phase III
1.3 Market by Application
1.3.1 Global Pediatric Clinical Trials Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neuropsychiatric Conditions
1.3.3 Infectious Diseases
1.3.4 Respiratory Diseases
1.3.5 Cardiovascular Diseases
1.3.6 Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Clinical Trials Market Perspective (2020-2031)
2.2 Global Pediatric Clinical Trials Growth Trends by Region
2.2.1 Global Pediatric Clinical Trials Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pediatric Clinical Trials Historic Market Size by Region (2020-2025)
2.2.3 Pediatric Clinical Trials Forecasted Market Size by Region (2026-2031)
2.3 Pediatric Clinical Trials Market Dynamics
2.3.1 Pediatric Clinical Trials Industry Trends
2.3.2 Pediatric Clinical Trials Market Drivers
2.3.3 Pediatric Clinical Trials Market Challenges
2.3.4 Pediatric Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Clinical Trials Players by Revenue
3.1.1 Global Top Pediatric Clinical Trials Players by Revenue (2020-2025)
3.1.2 Global Pediatric Clinical Trials Revenue Market Share by Players (2020-2025)
3.2 Global Pediatric Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Clinical Trials Revenue
3.4 Global Pediatric Clinical Trials Market Concentration Ratio
3.4.1 Global Pediatric Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Clinical Trials Revenue in 2024
3.5 Global Key Players of Pediatric Clinical Trials Head office and Area Served
3.6 Global Key Players of Pediatric Clinical Trials, Product and Application
3.7 Global Key Players of Pediatric Clinical Trials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Clinical Trials Breakdown Data by Type
4.1 Global Pediatric Clinical Trials Historic Market Size by Type (2020-2025)
4.2 Global Pediatric Clinical Trials Forecasted Market Size by Type (2026-2031)
5 Pediatric Clinical Trials Breakdown Data by Application
5.1 Global Pediatric Clinical Trials Historic Market Size by Application (2020-2025)
5.2 Global Pediatric Clinical Trials Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pediatric Clinical Trials Market Size (2020-2031)
6.2 North America Pediatric Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pediatric Clinical Trials Market Size by Country (2020-2025)
6.4 North America Pediatric Clinical Trials Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Clinical Trials Market Size (2020-2031)
7.2 Europe Pediatric Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pediatric Clinical Trials Market Size by Country (2020-2025)
7.4 Europe Pediatric Clinical Trials Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Clinical Trials Market Size (2020-2031)
8.2 Asia-Pacific Pediatric Clinical Trials Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pediatric Clinical Trials Market Size by Region (2020-2025)
8.4 Asia-Pacific Pediatric Clinical Trials Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Clinical Trials Market Size (2020-2031)
9.2 Latin America Pediatric Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pediatric Clinical Trials Market Size by Country (2020-2025)
9.4 Latin America Pediatric Clinical Trials Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Clinical Trials Market Size (2020-2031)
10.2 Middle East & Africa Pediatric Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pediatric Clinical Trials Market Size by Country (2020-2025)
10.4 Middle East & Africa Pediatric Clinical Trials Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA Holdings, Inc.
11.1.1 IQVIA Holdings, Inc. Company Details
11.1.2 IQVIA Holdings, Inc. Business Overview
11.1.3 IQVIA Holdings, Inc. Pediatric Clinical Trials Introduction
11.1.4 IQVIA Holdings, Inc. Revenue in Pediatric Clinical Trials Business (2020-2025)
11.1.5 IQVIA Holdings, Inc. Recent Development
11.2 Parexel International
11.2.1 Parexel International Company Details
11.2.2 Parexel International Business Overview
11.2.3 Parexel International Pediatric Clinical Trials Introduction
11.2.4 Parexel International Revenue in Pediatric Clinical Trials Business (2020-2025)
11.2.5 Parexel International Recent Development
11.3 CenterWatch
11.3.1 CenterWatch Company Details
11.3.2 CenterWatch Business Overview
11.3.3 CenterWatch Pediatric Clinical Trials Introduction
11.3.4 CenterWatch Revenue in Pediatric Clinical Trials Business (2020-2025)
11.3.5 CenterWatch Recent Development
11.4 Syneos Health
11.4.1 Syneos Health Company Details
11.4.2 Syneos Health Business Overview
11.4.3 Syneos Health Pediatric Clinical Trials Introduction
11.4.4 Syneos Health Revenue in Pediatric Clinical Trials Business (2020-2025)
11.4.5 Syneos Health Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Details
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Pediatric Clinical Trials Introduction
11.5.4 Charles River Laboratories Revenue in Pediatric Clinical Trials Business (2020-2025)
11.5.5 Charles River Laboratories Recent Development
11.6 Covance Inc.
11.6.1 Covance Inc. Company Details
11.6.2 Covance Inc. Business Overview
11.6.3 Covance Inc. Pediatric Clinical Trials Introduction
11.6.4 Covance Inc. Revenue in Pediatric Clinical Trials Business (2020-2025)
11.6.5 Covance Inc. Recent Development
11.7 ICON Plc.
11.7.1 ICON Plc. Company Details
11.7.2 ICON Plc. Business Overview
11.7.3 ICON Plc. Pediatric Clinical Trials Introduction
11.7.4 ICON Plc. Revenue in Pediatric Clinical Trials Business (2020-2025)
11.7.5 ICON Plc. Recent Development
11.8 Pharmaceutical Product Development, LLC.
11.8.1 Pharmaceutical Product Development, LLC. Company Details
11.8.2 Pharmaceutical Product Development, LLC. Business Overview
11.8.3 Pharmaceutical Product Development, LLC. Pediatric Clinical Trials Introduction
11.8.4 Pharmaceutical Product Development, LLC. Revenue in Pediatric Clinical Trials Business (2020-2025)
11.8.5 Pharmaceutical Product Development, LLC. Recent Development
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Details
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Pediatric Clinical Trials Introduction
11.9.4 Genentech (Roche) Revenue in Pediatric Clinical Trials Business (2020-2025)
11.9.5 Genentech (Roche) Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Pediatric Clinical Trials Introduction
11.10.4 Pfizer Revenue in Pediatric Clinical Trials Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Pediatric Clinical Trials Introduction
11.11.4 Bristol-Myers Squibb Revenue in Pediatric Clinical Trials Business (2020-2025)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Details
11.12.2 GlaxoSmithKline Business Overview
11.12.3 GlaxoSmithKline Pediatric Clinical Trials Introduction
11.12.4 GlaxoSmithKline Revenue in Pediatric Clinical Trials Business (2020-2025)
11.12.5 GlaxoSmithKline Recent Development
11.13 Sanofi S.A.
11.13.1 Sanofi S.A. Company Details
11.13.2 Sanofi S.A. Business Overview
11.13.3 Sanofi S.A. Pediatric Clinical Trials Introduction
11.13.4 Sanofi S.A. Revenue in Pediatric Clinical Trials Business (2020-2025)
11.13.5 Sanofi S.A. Recent Development
11.14 Novartis AG
11.14.1 Novartis AG Company Details
11.14.2 Novartis AG Business Overview
11.14.3 Novartis AG Pediatric Clinical Trials Introduction
11.14.4 Novartis AG Revenue in Pediatric Clinical Trials Business (2020-2025)
11.14.5 Novartis AG Recent Development
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Details
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson Pediatric Clinical Trials Introduction
11.15.4 Johnson & Johnson Revenue in Pediatric Clinical Trials Business (2020-2025)
11.15.5 Johnson & Johnson Recent Development
11.16 Shire (Takeda)
11.16.1 Shire (Takeda) Company Details
11.16.2 Shire (Takeda) Business Overview
11.16.3 Shire (Takeda) Pediatric Clinical Trials Introduction
11.16.4 Shire (Takeda) Revenue in Pediatric Clinical Trials Business (2020-2025)
11.16.5 Shire (Takeda) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Clinical Trials Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pre-Clinical Phase
1.2.3 Phase I
1.2.4 Phase II
1.2.5 Phase III
1.3 Market by Application
1.3.1 Global Pediatric Clinical Trials Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neuropsychiatric Conditions
1.3.3 Infectious Diseases
1.3.4 Respiratory Diseases
1.3.5 Cardiovascular Diseases
1.3.6 Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Clinical Trials Market Perspective (2020-2031)
2.2 Global Pediatric Clinical Trials Growth Trends by Region
2.2.1 Global Pediatric Clinical Trials Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pediatric Clinical Trials Historic Market Size by Region (2020-2025)
2.2.3 Pediatric Clinical Trials Forecasted Market Size by Region (2026-2031)
2.3 Pediatric Clinical Trials Market Dynamics
2.3.1 Pediatric Clinical Trials Industry Trends
2.3.2 Pediatric Clinical Trials Market Drivers
2.3.3 Pediatric Clinical Trials Market Challenges
2.3.4 Pediatric Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Clinical Trials Players by Revenue
3.1.1 Global Top Pediatric Clinical Trials Players by Revenue (2020-2025)
3.1.2 Global Pediatric Clinical Trials Revenue Market Share by Players (2020-2025)
3.2 Global Pediatric Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Clinical Trials Revenue
3.4 Global Pediatric Clinical Trials Market Concentration Ratio
3.4.1 Global Pediatric Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Clinical Trials Revenue in 2024
3.5 Global Key Players of Pediatric Clinical Trials Head office and Area Served
3.6 Global Key Players of Pediatric Clinical Trials, Product and Application
3.7 Global Key Players of Pediatric Clinical Trials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Clinical Trials Breakdown Data by Type
4.1 Global Pediatric Clinical Trials Historic Market Size by Type (2020-2025)
4.2 Global Pediatric Clinical Trials Forecasted Market Size by Type (2026-2031)
5 Pediatric Clinical Trials Breakdown Data by Application
5.1 Global Pediatric Clinical Trials Historic Market Size by Application (2020-2025)
5.2 Global Pediatric Clinical Trials Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pediatric Clinical Trials Market Size (2020-2031)
6.2 North America Pediatric Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pediatric Clinical Trials Market Size by Country (2020-2025)
6.4 North America Pediatric Clinical Trials Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Clinical Trials Market Size (2020-2031)
7.2 Europe Pediatric Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pediatric Clinical Trials Market Size by Country (2020-2025)
7.4 Europe Pediatric Clinical Trials Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Clinical Trials Market Size (2020-2031)
8.2 Asia-Pacific Pediatric Clinical Trials Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pediatric Clinical Trials Market Size by Region (2020-2025)
8.4 Asia-Pacific Pediatric Clinical Trials Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Clinical Trials Market Size (2020-2031)
9.2 Latin America Pediatric Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pediatric Clinical Trials Market Size by Country (2020-2025)
9.4 Latin America Pediatric Clinical Trials Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Clinical Trials Market Size (2020-2031)
10.2 Middle East & Africa Pediatric Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pediatric Clinical Trials Market Size by Country (2020-2025)
10.4 Middle East & Africa Pediatric Clinical Trials Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA Holdings, Inc.
11.1.1 IQVIA Holdings, Inc. Company Details
11.1.2 IQVIA Holdings, Inc. Business Overview
11.1.3 IQVIA Holdings, Inc. Pediatric Clinical Trials Introduction
11.1.4 IQVIA Holdings, Inc. Revenue in Pediatric Clinical Trials Business (2020-2025)
11.1.5 IQVIA Holdings, Inc. Recent Development
11.2 Parexel International
11.2.1 Parexel International Company Details
11.2.2 Parexel International Business Overview
11.2.3 Parexel International Pediatric Clinical Trials Introduction
11.2.4 Parexel International Revenue in Pediatric Clinical Trials Business (2020-2025)
11.2.5 Parexel International Recent Development
11.3 CenterWatch
11.3.1 CenterWatch Company Details
11.3.2 CenterWatch Business Overview
11.3.3 CenterWatch Pediatric Clinical Trials Introduction
11.3.4 CenterWatch Revenue in Pediatric Clinical Trials Business (2020-2025)
11.3.5 CenterWatch Recent Development
11.4 Syneos Health
11.4.1 Syneos Health Company Details
11.4.2 Syneos Health Business Overview
11.4.3 Syneos Health Pediatric Clinical Trials Introduction
11.4.4 Syneos Health Revenue in Pediatric Clinical Trials Business (2020-2025)
11.4.5 Syneos Health Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Details
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Pediatric Clinical Trials Introduction
11.5.4 Charles River Laboratories Revenue in Pediatric Clinical Trials Business (2020-2025)
11.5.5 Charles River Laboratories Recent Development
11.6 Covance Inc.
11.6.1 Covance Inc. Company Details
11.6.2 Covance Inc. Business Overview
11.6.3 Covance Inc. Pediatric Clinical Trials Introduction
11.6.4 Covance Inc. Revenue in Pediatric Clinical Trials Business (2020-2025)
11.6.5 Covance Inc. Recent Development
11.7 ICON Plc.
11.7.1 ICON Plc. Company Details
11.7.2 ICON Plc. Business Overview
11.7.3 ICON Plc. Pediatric Clinical Trials Introduction
11.7.4 ICON Plc. Revenue in Pediatric Clinical Trials Business (2020-2025)
11.7.5 ICON Plc. Recent Development
11.8 Pharmaceutical Product Development, LLC.
11.8.1 Pharmaceutical Product Development, LLC. Company Details
11.8.2 Pharmaceutical Product Development, LLC. Business Overview
11.8.3 Pharmaceutical Product Development, LLC. Pediatric Clinical Trials Introduction
11.8.4 Pharmaceutical Product Development, LLC. Revenue in Pediatric Clinical Trials Business (2020-2025)
11.8.5 Pharmaceutical Product Development, LLC. Recent Development
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Details
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Pediatric Clinical Trials Introduction
11.9.4 Genentech (Roche) Revenue in Pediatric Clinical Trials Business (2020-2025)
11.9.5 Genentech (Roche) Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Pediatric Clinical Trials Introduction
11.10.4 Pfizer Revenue in Pediatric Clinical Trials Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Pediatric Clinical Trials Introduction
11.11.4 Bristol-Myers Squibb Revenue in Pediatric Clinical Trials Business (2020-2025)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Details
11.12.2 GlaxoSmithKline Business Overview
11.12.3 GlaxoSmithKline Pediatric Clinical Trials Introduction
11.12.4 GlaxoSmithKline Revenue in Pediatric Clinical Trials Business (2020-2025)
11.12.5 GlaxoSmithKline Recent Development
11.13 Sanofi S.A.
11.13.1 Sanofi S.A. Company Details
11.13.2 Sanofi S.A. Business Overview
11.13.3 Sanofi S.A. Pediatric Clinical Trials Introduction
11.13.4 Sanofi S.A. Revenue in Pediatric Clinical Trials Business (2020-2025)
11.13.5 Sanofi S.A. Recent Development
11.14 Novartis AG
11.14.1 Novartis AG Company Details
11.14.2 Novartis AG Business Overview
11.14.3 Novartis AG Pediatric Clinical Trials Introduction
11.14.4 Novartis AG Revenue in Pediatric Clinical Trials Business (2020-2025)
11.14.5 Novartis AG Recent Development
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Details
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson Pediatric Clinical Trials Introduction
11.15.4 Johnson & Johnson Revenue in Pediatric Clinical Trials Business (2020-2025)
11.15.5 Johnson & Johnson Recent Development
11.16 Shire (Takeda)
11.16.1 Shire (Takeda) Company Details
11.16.2 Shire (Takeda) Business Overview
11.16.3 Shire (Takeda) Pediatric Clinical Trials Introduction
11.16.4 Shire (Takeda) Revenue in Pediatric Clinical Trials Business (2020-2025)
11.16.5 Shire (Takeda) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pediatric Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Pre-Clinical Phase
Table 3. Key Players of Phase I
Table 4. Key Players of Phase II
Table 5. Key Players of Phase III
Table 6. Global Pediatric Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pediatric Clinical Trials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pediatric Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Pediatric Clinical Trials Market Share by Region (2020-2025)
Table 10. Global Pediatric Clinical Trials Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Pediatric Clinical Trials Market Share by Region (2026-2031)
Table 12. Pediatric Clinical Trials Market Trends
Table 13. Pediatric Clinical Trials Market Drivers
Table 14. Pediatric Clinical Trials Market Challenges
Table 15. Pediatric Clinical Trials Market Restraints
Table 16. Global Pediatric Clinical Trials Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Pediatric Clinical Trials Market Share by Players (2020-2025)
Table 18. Global Top Pediatric Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Clinical Trials as of 2024)
Table 19. Ranking of Global Top Pediatric Clinical Trials Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Pediatric Clinical Trials Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Pediatric Clinical Trials, Headquarters and Area Served
Table 22. Global Key Players of Pediatric Clinical Trials, Product and Application
Table 23. Global Key Players of Pediatric Clinical Trials, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pediatric Clinical Trials Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Pediatric Clinical Trials Revenue Market Share by Type (2020-2025)
Table 27. Global Pediatric Clinical Trials Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Pediatric Clinical Trials Revenue Market Share by Type (2026-2031)
Table 29. Global Pediatric Clinical Trials Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Pediatric Clinical Trials Revenue Market Share by Application (2020-2025)
Table 31. Global Pediatric Clinical Trials Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Pediatric Clinical Trials Revenue Market Share by Application (2026-2031)
Table 33. North America Pediatric Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Pediatric Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Pediatric Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Pediatric Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Pediatric Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Pediatric Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Pediatric Clinical Trials Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Pediatric Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Pediatric Clinical Trials Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Pediatric Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Pediatric Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pediatric Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Pediatric Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Pediatric Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Pediatric Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 48. IQVIA Holdings, Inc. Company Details
Table 49. IQVIA Holdings, Inc. Business Overview
Table 50. IQVIA Holdings, Inc. Pediatric Clinical Trials Product
Table 51. IQVIA Holdings, Inc. Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 52. IQVIA Holdings, Inc. Recent Development
Table 53. Parexel International Company Details
Table 54. Parexel International Business Overview
Table 55. Parexel International Pediatric Clinical Trials Product
Table 56. Parexel International Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 57. Parexel International Recent Development
Table 58. CenterWatch Company Details
Table 59. CenterWatch Business Overview
Table 60. CenterWatch Pediatric Clinical Trials Product
Table 61. CenterWatch Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 62. CenterWatch Recent Development
Table 63. Syneos Health Company Details
Table 64. Syneos Health Business Overview
Table 65. Syneos Health Pediatric Clinical Trials Product
Table 66. Syneos Health Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 67. Syneos Health Recent Development
Table 68. Charles River Laboratories Company Details
Table 69. Charles River Laboratories Business Overview
Table 70. Charles River Laboratories Pediatric Clinical Trials Product
Table 71. Charles River Laboratories Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 72. Charles River Laboratories Recent Development
Table 73. Covance Inc. Company Details
Table 74. Covance Inc. Business Overview
Table 75. Covance Inc. Pediatric Clinical Trials Product
Table 76. Covance Inc. Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 77. Covance Inc. Recent Development
Table 78. ICON Plc. Company Details
Table 79. ICON Plc. Business Overview
Table 80. ICON Plc. Pediatric Clinical Trials Product
Table 81. ICON Plc. Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 82. ICON Plc. Recent Development
Table 83. Pharmaceutical Product Development, LLC. Company Details
Table 84. Pharmaceutical Product Development, LLC. Business Overview
Table 85. Pharmaceutical Product Development, LLC. Pediatric Clinical Trials Product
Table 86. Pharmaceutical Product Development, LLC. Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 87. Pharmaceutical Product Development, LLC. Recent Development
Table 88. Genentech (Roche) Company Details
Table 89. Genentech (Roche) Business Overview
Table 90. Genentech (Roche) Pediatric Clinical Trials Product
Table 91. Genentech (Roche) Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 92. Genentech (Roche) Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Pediatric Clinical Trials Product
Table 96. Pfizer Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Bristol-Myers Squibb Company Details
Table 99. Bristol-Myers Squibb Business Overview
Table 100. Bristol-Myers Squibb Pediatric Clinical Trials Product
Table 101. Bristol-Myers Squibb Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 102. Bristol-Myers Squibb Recent Development
Table 103. GlaxoSmithKline Company Details
Table 104. GlaxoSmithKline Business Overview
Table 105. GlaxoSmithKline Pediatric Clinical Trials Product
Table 106. GlaxoSmithKline Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 107. GlaxoSmithKline Recent Development
Table 108. Sanofi S.A. Company Details
Table 109. Sanofi S.A. Business Overview
Table 110. Sanofi S.A. Pediatric Clinical Trials Product
Table 111. Sanofi S.A. Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 112. Sanofi S.A. Recent Development
Table 113. Novartis AG Company Details
Table 114. Novartis AG Business Overview
Table 115. Novartis AG Pediatric Clinical Trials Product
Table 116. Novartis AG Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 117. Novartis AG Recent Development
Table 118. Johnson & Johnson Company Details
Table 119. Johnson & Johnson Business Overview
Table 120. Johnson & Johnson Pediatric Clinical Trials Product
Table 121. Johnson & Johnson Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 122. Johnson & Johnson Recent Development
Table 123. Shire (Takeda) Company Details
Table 124. Shire (Takeda) Business Overview
Table 125. Shire (Takeda) Pediatric Clinical Trials Product
Table 126. Shire (Takeda) Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 127. Shire (Takeda) Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Pediatric Clinical Trials Picture
Figure 2. Global Pediatric Clinical Trials Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pediatric Clinical Trials Market Share by Type: 2024 VS 2031
Figure 4. Pre-Clinical Phase Features
Figure 5. Phase I Features
Figure 6. Phase II Features
Figure 7. Phase III Features
Figure 8. Global Pediatric Clinical Trials Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Pediatric Clinical Trials Market Share by Application: 2024 VS 2031
Figure 10. Neuropsychiatric Conditions Case Studies
Figure 11. Infectious Diseases Case Studies
Figure 12. Respiratory Diseases Case Studies
Figure 13. Cardiovascular Diseases Case Studies
Figure 14. Cancer Case Studies
Figure 15. Others Case Studies
Figure 16. Pediatric Clinical Trials Report Years Considered
Figure 17. Global Pediatric Clinical Trials Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Pediatric Clinical Trials Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Pediatric Clinical Trials Market Share by Region: 2024 VS 2031
Figure 20. Global Pediatric Clinical Trials Market Share by Players in 2024
Figure 21. Global Top Pediatric Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Clinical Trials as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Pediatric Clinical Trials Revenue in 2024
Figure 23. North America Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Pediatric Clinical Trials Market Share by Country (2020-2031)
Figure 25. United States Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Pediatric Clinical Trials Market Share by Country (2020-2031)
Figure 29. Germany Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Pediatric Clinical Trials Market Share by Region (2020-2031)
Figure 37. China Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Pediatric Clinical Trials Market Share by Country (2020-2031)
Figure 45. Mexico Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Pediatric Clinical Trials Market Share by Country (2020-2031)
Figure 49. Turkey Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. IQVIA Holdings, Inc. Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 53. Parexel International Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 54. CenterWatch Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 55. Syneos Health Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 56. Charles River Laboratories Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 57. Covance Inc. Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 58. ICON Plc. Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 59. Pharmaceutical Product Development, LLC. Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 60. Genentech (Roche) Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 61. Pfizer Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 64. Sanofi S.A. Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 65. Novartis AG Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 66. Johnson & Johnson Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 67. Shire (Takeda) Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Pediatric Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Pre-Clinical Phase
Table 3. Key Players of Phase I
Table 4. Key Players of Phase II
Table 5. Key Players of Phase III
Table 6. Global Pediatric Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pediatric Clinical Trials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pediatric Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Pediatric Clinical Trials Market Share by Region (2020-2025)
Table 10. Global Pediatric Clinical Trials Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Pediatric Clinical Trials Market Share by Region (2026-2031)
Table 12. Pediatric Clinical Trials Market Trends
Table 13. Pediatric Clinical Trials Market Drivers
Table 14. Pediatric Clinical Trials Market Challenges
Table 15. Pediatric Clinical Trials Market Restraints
Table 16. Global Pediatric Clinical Trials Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Pediatric Clinical Trials Market Share by Players (2020-2025)
Table 18. Global Top Pediatric Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Clinical Trials as of 2024)
Table 19. Ranking of Global Top Pediatric Clinical Trials Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Pediatric Clinical Trials Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Pediatric Clinical Trials, Headquarters and Area Served
Table 22. Global Key Players of Pediatric Clinical Trials, Product and Application
Table 23. Global Key Players of Pediatric Clinical Trials, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pediatric Clinical Trials Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Pediatric Clinical Trials Revenue Market Share by Type (2020-2025)
Table 27. Global Pediatric Clinical Trials Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Pediatric Clinical Trials Revenue Market Share by Type (2026-2031)
Table 29. Global Pediatric Clinical Trials Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Pediatric Clinical Trials Revenue Market Share by Application (2020-2025)
Table 31. Global Pediatric Clinical Trials Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Pediatric Clinical Trials Revenue Market Share by Application (2026-2031)
Table 33. North America Pediatric Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Pediatric Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Pediatric Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Pediatric Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Pediatric Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Pediatric Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Pediatric Clinical Trials Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Pediatric Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Pediatric Clinical Trials Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Pediatric Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Pediatric Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pediatric Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Pediatric Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Pediatric Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Pediatric Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 48. IQVIA Holdings, Inc. Company Details
Table 49. IQVIA Holdings, Inc. Business Overview
Table 50. IQVIA Holdings, Inc. Pediatric Clinical Trials Product
Table 51. IQVIA Holdings, Inc. Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 52. IQVIA Holdings, Inc. Recent Development
Table 53. Parexel International Company Details
Table 54. Parexel International Business Overview
Table 55. Parexel International Pediatric Clinical Trials Product
Table 56. Parexel International Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 57. Parexel International Recent Development
Table 58. CenterWatch Company Details
Table 59. CenterWatch Business Overview
Table 60. CenterWatch Pediatric Clinical Trials Product
Table 61. CenterWatch Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 62. CenterWatch Recent Development
Table 63. Syneos Health Company Details
Table 64. Syneos Health Business Overview
Table 65. Syneos Health Pediatric Clinical Trials Product
Table 66. Syneos Health Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 67. Syneos Health Recent Development
Table 68. Charles River Laboratories Company Details
Table 69. Charles River Laboratories Business Overview
Table 70. Charles River Laboratories Pediatric Clinical Trials Product
Table 71. Charles River Laboratories Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 72. Charles River Laboratories Recent Development
Table 73. Covance Inc. Company Details
Table 74. Covance Inc. Business Overview
Table 75. Covance Inc. Pediatric Clinical Trials Product
Table 76. Covance Inc. Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 77. Covance Inc. Recent Development
Table 78. ICON Plc. Company Details
Table 79. ICON Plc. Business Overview
Table 80. ICON Plc. Pediatric Clinical Trials Product
Table 81. ICON Plc. Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 82. ICON Plc. Recent Development
Table 83. Pharmaceutical Product Development, LLC. Company Details
Table 84. Pharmaceutical Product Development, LLC. Business Overview
Table 85. Pharmaceutical Product Development, LLC. Pediatric Clinical Trials Product
Table 86. Pharmaceutical Product Development, LLC. Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 87. Pharmaceutical Product Development, LLC. Recent Development
Table 88. Genentech (Roche) Company Details
Table 89. Genentech (Roche) Business Overview
Table 90. Genentech (Roche) Pediatric Clinical Trials Product
Table 91. Genentech (Roche) Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 92. Genentech (Roche) Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Pediatric Clinical Trials Product
Table 96. Pfizer Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Bristol-Myers Squibb Company Details
Table 99. Bristol-Myers Squibb Business Overview
Table 100. Bristol-Myers Squibb Pediatric Clinical Trials Product
Table 101. Bristol-Myers Squibb Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 102. Bristol-Myers Squibb Recent Development
Table 103. GlaxoSmithKline Company Details
Table 104. GlaxoSmithKline Business Overview
Table 105. GlaxoSmithKline Pediatric Clinical Trials Product
Table 106. GlaxoSmithKline Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 107. GlaxoSmithKline Recent Development
Table 108. Sanofi S.A. Company Details
Table 109. Sanofi S.A. Business Overview
Table 110. Sanofi S.A. Pediatric Clinical Trials Product
Table 111. Sanofi S.A. Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 112. Sanofi S.A. Recent Development
Table 113. Novartis AG Company Details
Table 114. Novartis AG Business Overview
Table 115. Novartis AG Pediatric Clinical Trials Product
Table 116. Novartis AG Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 117. Novartis AG Recent Development
Table 118. Johnson & Johnson Company Details
Table 119. Johnson & Johnson Business Overview
Table 120. Johnson & Johnson Pediatric Clinical Trials Product
Table 121. Johnson & Johnson Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 122. Johnson & Johnson Recent Development
Table 123. Shire (Takeda) Company Details
Table 124. Shire (Takeda) Business Overview
Table 125. Shire (Takeda) Pediatric Clinical Trials Product
Table 126. Shire (Takeda) Revenue in Pediatric Clinical Trials Business (2020-2025) & (US$ Million)
Table 127. Shire (Takeda) Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Pediatric Clinical Trials Picture
Figure 2. Global Pediatric Clinical Trials Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pediatric Clinical Trials Market Share by Type: 2024 VS 2031
Figure 4. Pre-Clinical Phase Features
Figure 5. Phase I Features
Figure 6. Phase II Features
Figure 7. Phase III Features
Figure 8. Global Pediatric Clinical Trials Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Pediatric Clinical Trials Market Share by Application: 2024 VS 2031
Figure 10. Neuropsychiatric Conditions Case Studies
Figure 11. Infectious Diseases Case Studies
Figure 12. Respiratory Diseases Case Studies
Figure 13. Cardiovascular Diseases Case Studies
Figure 14. Cancer Case Studies
Figure 15. Others Case Studies
Figure 16. Pediatric Clinical Trials Report Years Considered
Figure 17. Global Pediatric Clinical Trials Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Pediatric Clinical Trials Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Pediatric Clinical Trials Market Share by Region: 2024 VS 2031
Figure 20. Global Pediatric Clinical Trials Market Share by Players in 2024
Figure 21. Global Top Pediatric Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Clinical Trials as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Pediatric Clinical Trials Revenue in 2024
Figure 23. North America Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Pediatric Clinical Trials Market Share by Country (2020-2031)
Figure 25. United States Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Pediatric Clinical Trials Market Share by Country (2020-2031)
Figure 29. Germany Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Pediatric Clinical Trials Market Share by Region (2020-2031)
Figure 37. China Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Pediatric Clinical Trials Market Share by Country (2020-2031)
Figure 45. Mexico Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Pediatric Clinical Trials Market Share by Country (2020-2031)
Figure 49. Turkey Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Pediatric Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. IQVIA Holdings, Inc. Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 53. Parexel International Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 54. CenterWatch Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 55. Syneos Health Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 56. Charles River Laboratories Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 57. Covance Inc. Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 58. ICON Plc. Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 59. Pharmaceutical Product Development, LLC. Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 60. Genentech (Roche) Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 61. Pfizer Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 64. Sanofi S.A. Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 65. Novartis AG Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 66. Johnson & Johnson Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 67. Shire (Takeda) Revenue Growth Rate in Pediatric Clinical Trials Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232